These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4583150)

  • 21. Cimetidine does not accelerate skin graft rejection in mice.
    Festen HP; Berden JH; Koene RA
    Clin Exp Immunol; 1980 Apr; 40(1):193-6. PubMed ID: 6993076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [B. Delaying effect of levan on skin homograft rejection in mice].
    Strassman G; Bleiberg I
    Harefuah; 1977 Dec; 93(11):336-7. PubMed ID: 344170
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A further study on the genetic rules of transplantation in the mouse.
    Rogers K; Barnes AD
    Transplantation; 1974 Apr; 17(4):435-7. PubMed ID: 4595929
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of glutaraldehyde on skin grafts.
    Santiago-Delpin EA; Yunis EJ; Callender CO; Najarian JS
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):996-8. PubMed ID: 4566757
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes.
    Cevc G; Blume G
    Biochim Biophys Acta; 2003 Aug; 1614(2):156-64. PubMed ID: 12896808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CD30 in skin and heart allograft rejection in the mouse.
    Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
    Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on FK506 in experimental organ transplantation.
    Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of FK 506 on islet allograft rejection in mice and pigs.
    Nagata M; Yamaguchi T; Stein E; Mullen Y; Ochiai T
    Transplant Proc; 1991 Dec; 23(6):3213-6. PubMed ID: 1750090
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection.
    Steinmuller D; Wakely E; Landas SK
    Transplantation; 1991 Feb; 51(2):459-63. PubMed ID: 1994543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effects of cyclomunine on murine skin graft rejection.
    Kaiserlian D; Simon-Lavoine N
    Transplantation; 1982 Mar; 33(3):314-6. PubMed ID: 7039038
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance.
    Rockwell S; Kapp DS
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1071-3. PubMed ID: 7050051
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of murine skin allografts by prostaglandin E1.
    Anderson CB; Jaffee BM; Graff RJ
    Transplantation; 1977 May; 23(5):444-7. PubMed ID: 325711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "In vivo" standardization model for defining the dose-response-dependent graft-protective value of antilymphocyte sera.
    Réthy L; Osz E
    Dev Biol Stand; 1974; 27():233-5. PubMed ID: 4618536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects and side effects of corticosteroids in allotransplantation].
    Klaue P
    Fortschr Med; 1976 Mar; 94(9):491-500. PubMed ID: 786840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice.
    Mertin J; Hunt R
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):928-31. PubMed ID: 768987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
    Spandau UH; Sauder G; Schubert U; Hammes HP; Jonas JB
    Br J Ophthalmol; 2005 Jun; 89(6):745-7. PubMed ID: 15923512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
    Floersheim GL
    Transplantation; 1973 Feb; 15(2):195-205. PubMed ID: 4146168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.